Wired article
There's a wired article on the fifty hippest companies. It makes for interesting reading.
http://www.wired.com/wired/archive/13.05/wired40.html
35. GEN-PROBE
A Germ's Worst Nightmare
Last year: 33
Someday doctors will use genomic data to prevent infectious diseases. Until then, there's Gen-Probe, whose nucleic acid tests detect scourges like hepatitis, HIV, pneumonia, and tuberculosis. Forty Gen-Probe products have gained FDA approval; its Procleix assay now screens more than 80 percent of the US blood supply. The result is fewer blood-borne infections, not to mention 2004 sales of $270 million and gross margins of 78 percent. That's one healthy business.
Challenge: Keep its big partners happy. Gen-Probe has been embroiled in contractual disputes with two, Chiron and Bayer.
Opportunity: Developing nations, where 43 percent of blood donations aren't tested for disease.
http://www.wired.com/wired/archive/13.05/wired40.html
35. GEN-PROBE
A Germ's Worst Nightmare
Last year: 33
Someday doctors will use genomic data to prevent infectious diseases. Until then, there's Gen-Probe, whose nucleic acid tests detect scourges like hepatitis, HIV, pneumonia, and tuberculosis. Forty Gen-Probe products have gained FDA approval; its Procleix assay now screens more than 80 percent of the US blood supply. The result is fewer blood-borne infections, not to mention 2004 sales of $270 million and gross margins of 78 percent. That's one healthy business.
Challenge: Keep its big partners happy. Gen-Probe has been embroiled in contractual disputes with two, Chiron and Bayer.
Opportunity: Developing nations, where 43 percent of blood donations aren't tested for disease.
0 Comments:
Post a Comment
<< Home